Recent publications
-
ACCESS TO HEPATITIS C TREATMENT AND CARE AMONG PEOPLE WHO INJECT DRUGS: FAILING PEOPLE MOST DISPROPORTIONATELY AFFECTED ISSUE BRIEF
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans. There is scarce information about how people who inject drugs (PWID) are factored into national (...) More
-
WHO HAS ACCESS TO HEPATITIS C TESTING? LIBERATE OUR DIAGNOSTICS! ISSUE BRIEF
Accurate, high-quality data on the hepatitis C virus (HCV) continues to be a struggle for countries that are scaling up testing services and linking people to treatment and care, as part of implementing their national hepatitis plans. There is very little in-country information about the (...) More
-
Activist Guide to Hepatitis C Virus Diagnostics
Out Now! A NEW Activist Guide to Hepatitis C Virus (HCV) Diagnostics is to provide information for you and your community. The Activist Guide aims to provide a deeper focus on diagnosis with updated information about the steps and different technologies involved in diagnosing a person with (...) More
-
Strengthening Advocacy for Hepatitis C Diagnostics: Malaysia Workshop Summary Report
1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More -
Strengthening Advocacy for Hepatitis C Diagnostics: Georgia Workshop Summary Report
13-15 May 2019, Tbilisi, Georgia
The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More